Nymalize 30 mg/5mL (Nimodipine SOLUTION) 30 mg/5mL

Nymalize 30 mg/5mL is an oral solution containing nimodipine, used for managing certain neurological conditions. This medication is designed to support vascular health and is available in a convenient liquid form.

Strength

30 mg/5mL

Pack Size

12 PACKAGE in 1 CARTON (24338-230-12) / 1 SYRINGE, PLASTIC in 1 PACKAGE (24338-230-05) / 5 mL in 1

Manufacturer / TM Owner

Azurity Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Nymalize 30 mg/5mL is primarily used for its effects on blood vessels in the brain. It is often prescribed to help manage conditions related to cerebral blood flow. People may ask, 'What is Nymalize used for?' This medication is typically used to support vascular health and may be part of a treatment plan for neurological conditions.

Side Effects

Common effects of Nymalize 30 mg/5mL may include changes in blood pressure and heart rate. Some users might experience dizziness or headaches. These effects can vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Nymalize 30 mg/5mL should be handled with care. It is important to follow the instructions provided by your healthcare provider. Store the medication as directed and keep it out of reach of children. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Nymalize 30 mg/5mL may interact with other medications, including those that affect blood pressure or heart rate. It is important to discuss all your current medications with your healthcare provider to avoid potential interactions. Alcohol and certain foods may also interact with this medication.

Frequently Asked Questions

Nymalize 30 mg/5mL is used to support vascular health and manage conditions related to cerebral blood flow.

Nymalize 30 mg/5mL is an oral solution and should be taken as directed by your healthcare provider.

Common effects may include changes in blood pressure, heart rate, dizziness, or headaches.

It is important to discuss all your current medications with your healthcare provider to avoid potential interactions.

Store Nymalize 30 mg/5mL as directed by your healthcare provider, typically at room temperature and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.